Cue Health’s Molecular Mpox Test Gets FDA EUA
Cue Health has received EUA from the U.S. Food and Drug Administration (FDA) for its molecular test to detect the mpox (monkeypox) virus.
Read More
Search Results for: point-of-care
Why Multiplex Testing Will Become the Diagnostic Standard of Care
Though not a new diagnostic technique, multiplex testing is poised to become the standard of diagnostic care in the post-pandemic world.
Read More
AXIM Biotechnologies Files Provisional Patent on Optical Diagnostic Assay Manufacturing Method
AXIM filed a provisional patent application with the USPTO to significantly increase sample disbursement of its ocular diagnostic assays.
Read More
‘Glow-in-the-Dark’ Proteins Could Help Diagnose Viral Diseases
Researchers developed a sensitive method that analyzes viral nucleic acids and can be completed in one step with “glow-in-the-dark” proteins.
Read More
Visby Medical’s STI Test for Women Gets FDA Clearance, CLIA Waiver
Visby Medical has received 510(k) clearance and was granted a CLIA waiver from the FDA for its second-generation POC sexual health test.
Read More